Schäfer H, Schwarzhoff R, Creutzfeldt W, Schmidt W E
Department of Medicine, Georg-August-University, Göttingen, Federal Republic of Germany.
Eur J Biochem. 1991 Dec 18;202(3):951-8. doi: 10.1111/j.1432-1033.1991.tb16455.x.
Pituitary adenylate-cyclase-activating polypeptide (PACAP), a novel brain-gut hormone, was isolated from ovine hypothalami and represents the latest mammalian member of the secretin-glucagon peptide family. PACAP exists in two C-terminally amidated molecular forms, PACAP(1-27) and PACAP(1-38), comprising 27 or 38 amino acid residues, respectively. In order to identify a specific receptor for PACAP, we studied binding of 125I-labelled PACAP(1-27) to plasma membranes from rat brain. We identified a single high-affinity binding site (Kd, 340 pM and Bmax, 3.34 pmol/mg), specific for synthetic PACAP(1-38) and PACAP(1-27). Hormone binding was reversible and time, protein and temperature dependent. In contrast, neither the analogues PACAP(1-23), PACAP(18-38) and PACAP(3-25), nor vasoactive intestinal peptide (VIP), secretin and growth-hormone-releasing factor (GRF) revealed significant binding at concentrations up to 1 microM. A specific receptor protein, with an apparent molecular mass of 60 kDa, was identified by means of affinity cross-linking with disuccinimidyl suberate (DSS) and ethylene glycol disuccinimidyl suberate (EGS). PACAP receptors are associated with a GTP-binding protein as determined by the influence of different nucleotides on PACAP binding. PACAP-binding activity was solubilized with the detergents 3-[(3-cholamidopropyl)dimethylammonio]2-hydroxy-1-propane sulfonate (Chapso) or Triton X-100 and was characterized as a high-molecular-mass receptor complex (400 kDa) by non-reducing size-exclusion chromatography on Sepharose CL-6B. These data imply the following: high-affinity PACAP receptors are expressed abundantly on rat-brain plasma membranes; PACAP receptors are specific for PACAP and show no affinity for VIP, secretin and GRF; the PACAP receptor molecule has an apparent molecular mass of 60 kDa; the PACAP receptor complex is associated with a GTP-binding protein.
垂体腺苷酸环化酶激活多肽(PACAP)是一种新型的脑肠肽,从羊下丘脑分离得到,是促胰液素 - 胰高血糖素肽家族的最新哺乳动物成员。PACAP以两种C末端酰胺化的分子形式存在,即PACAP(1 - 27)和PACAP(1 - 38),分别由27个或38个氨基酸残基组成。为了鉴定PACAP的特异性受体,我们研究了125I标记的PACAP(1 - 27)与大鼠脑细胞膜的结合。我们鉴定出一个单一的高亲和力结合位点(解离常数Kd为340 pM,最大结合容量Bmax为3.34 pmol/mg),对合成的PACAP(1 - 38)和PACAP(1 - 27)具有特异性。激素结合是可逆的,且与时间、蛋白质和温度有关。相比之下,PACAP(1 - 23)、PACAP(18 - 38)和PACAP(3 - 25)类似物,以及血管活性肠肽(VIP)、促胰液素和生长激素释放因子(GRF)在浓度高达1 microM时均未显示出明显的结合。通过与辛二酸二琥珀酰亚胺酯(DSS)和乙二醇二琥珀酰亚胺酯(EGS)进行亲和交联,鉴定出一种表观分子量为60 kDa的特异性受体蛋白。根据不同核苷酸对PACAP结合的影响确定,PACAP受体与一种GTP结合蛋白相关。用去污剂3 - [(3 - 胆酰胺丙基)二甲基铵基] - 2 - 羟基 - 1 - 丙烷磺酸盐(Chapso)或Triton X - 100可使PACAP结合活性溶解,并通过在Sepharose CL - 6B上进行非还原尺寸排阻色谱法将其表征为高分子量受体复合物(400 kDa)。这些数据表明:高亲和力的PACAP受体在大鼠脑细胞膜上大量表达;PACAP受体对PACAP具有特异性,对VIP、促胰液素和GRF无亲和力;PACAP受体分子的表观分子量为60 kDa;PACAP受体复合物与一种GTP结合蛋白相关。